日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Regulator of G-protein signaling rgs-6 (rgs-6), partial CSB-YP619224CXY
CSB-EP619224CXY
CSB-BP619224CXY
CSB-MP619224CXY
CSB-EP619224CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Ribosome-recycling factor (frr) CSB-YP619225CAAQ
CSB-EP619225CAAQ
CSB-BP619225CAAQ
CSB-MP619225CAAQ
CSB-EP619225CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized zinc metalloprotease C44B7.11 (C44B7.11), partial CSB-YP619226CXY
CSB-EP619226CXY
CSB-BP619226CXY
CSB-MP619226CXY
CSB-EP619226CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heat shock protein 90 (daf-21), partial CSB-YP619227CXY
CSB-EP619227CXY
CSB-BP619227CXY
CSB-MP619227CXY
CSB-EP619227CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable small nuclear ribonucleoprotein Sm D2 (snr-4) CSB-YP619228CXY
CSB-EP619228CXY
CSB-BP619228CXY
CSB-MP619228CXY
CSB-EP619228CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile UPF0246 protein CD630_18230 (CD630_18230) CSB-YP619229CAAQ
CSB-EP619229CAAQ
CSB-BP619229CAAQ
CSB-MP619229CAAQ
CSB-EP619229CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Phosphate propanoyltransferase (pduL) CSB-YP619230CAAQ
CSB-EP619230CAAQ
CSB-BP619230CAAQ
CSB-MP619230CAAQ
CSB-EP619230CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile DNA mismatch repair protein MutS (mutS), partial CSB-YP619231CAAQ
CSB-EP619231CAAQ
CSB-BP619231CAAQ
CSB-MP619231CAAQ
CSB-EP619231CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serpentine receptor class r-10 (odr-10), partial CSB-YP619232CXY1
CSB-EP619232CXY1
CSB-BP619232CXY1
CSB-MP619232CXY1
CSB-EP619232CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Transcription factor BTF3 homolog (icd-1) CSB-YP619233CXY
CSB-EP619233CXY
CSB-BP619233CXY
CSB-MP619233CXY
CSB-EP619233CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant O-phosphoseryl-tRNA (Sec) selenium transferase (secs-1) CSB-YP619234CXY
CSB-EP619234CXY
CSB-BP619234CXY
CSB-MP619234CXY
CSB-EP619234CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Arginine--tRNA ligase (argS), partial CSB-YP619235CAAQ
CSB-EP619235CAAQ
CSB-BP619235CAAQ
CSB-MP619235CAAQ
CSB-EP619235CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Glycogen synthase (glgA) CSB-YP619236CAAQ
CSB-EP619236CAAQ
CSB-BP619236CAAQ
CSB-MP619236CAAQ
CSB-EP619236CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile UPF0758 protein CD630_11440 (CD630_11440) CSB-YP619237CAAQ
CSB-EP619237CAAQ
CSB-BP619237CAAQ
CSB-MP619237CAAQ
CSB-EP619237CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Cell division topological specificity factor (minE) CSB-YP619238CAAQ
CSB-EP619238CAAQ
CSB-BP619238CAAQ
CSB-MP619238CAAQ
CSB-EP619238CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Acetate kinase (ackA) CSB-YP619239CAAQ
CSB-EP619239CAAQ
CSB-BP619239CAAQ
CSB-MP619239CAAQ
CSB-EP619239CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Phosphopentomutase (deoB) CSB-YP619240CAAQ
CSB-EP619240CAAQ
CSB-BP619240CAAQ
CSB-MP619240CAAQ
CSB-EP619240CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP619241CAAQ
CSB-EP619241CAAQ
CSB-BP619241CAAQ
CSB-MP619241CAAQ
CSB-EP619241CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Segregation and condensation protein B (scpB) CSB-YP619242CAAQ
CSB-EP619242CAAQ
CSB-BP619242CAAQ
CSB-MP619242CAAQ
CSB-EP619242CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Undecaprenyl-diphosphatase 1 (uppP1), partial CSB-YP619243CAAQ
CSB-EP619243CAAQ
CSB-BP619243CAAQ
CSB-MP619243CAAQ
CSB-EP619243CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×